Utilization study in real clinical practice of ceftolozane/tazobactam vs aminoglycosides and/or colistin in the treatment of multirresistant or extremely resistant Pseudomonas aeruginosa

CONCLUSIONS: The data obtained suggest that there have been no differences in effectiveness (clinical or microbiological cure) in favour of C/T, although, in the period studied, it was used in most cases in multitreated patients with a worse prognosis. Randomized and prospective studies would be needed to establish an adequate positioning.PMID:34154319 | DOI:10.37201/req/006.2021

Source: Revista Espanola de Quimioterapia - June 22, 2021 Category: Drugs & Pharmacology Authors: A Pinilla-Rello R Huarte-Lacunza A Magall ón-Martínez L Cazorla-Poderoso O Pereira-Blanco M P érez-Moreno I Larrod é-Leciñena R M Mart ínez-Álvarez A I L ópez-Calleja Source Type: research